Patient Anxiety During Magnetic Resonance Imaging
Recruiting · NCT07671846 · Observational (researchers observe without assigning treatment) · Lead sponsor: European Institute of Oncology
View the official record on ClinicalTrials.gov →What this trial is about
This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.
Who can take part
Inclusion criteria
- Cancer patients who will perform a WB-MRI in their clinical path
- Age ≥ 18 years
- Patients able to speak and read the local language(s) fluently.
- Patients with no concomitant neurological or psychiatric disorders.
- Acceptance and signature of informed consent
Exclusion criteria
- Absolute contraindication to WB-MRI
- Previous cancer-related medical treatments or other treatments that could have altered patients' cognition
Where it is running
1 location listed.
- European Institute of Oncology, Milan - Milan, Mi, Italy